GATA6 loss-of-function mutation in atrial fibrillation

European Journal of Medical Genetics

Volumn 55, Issue 10, 2012, Pages 520-526

  Yang, Yi Qing ^a   Li, Li ^b   Wang, Juan ^b   Zhang, Xian Ling ^a   Li, Ruo Gu ^a   Xu, Ying Jia ^a   Tan, Hong Wei ^a   Wang, Xin Hua ^a   Jiang, Jin Qi ^a   Fang, Wei Yi ^a   Liu, Xu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atrial fibrillation; Genetics; Transcription factor

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; LUCIFERASE; TRANSCRIPTION FACTOR GATA 6; WARFARIN;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GATA6 GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE; REPORTER GENE; SEQUENCE ALIGNMENT; TRANSCRIPTION REGULATION;

ADULT; ATRIAL FIBRILLATION; FEMALE; GATA6 TRANSCRIPTION FACTOR; GENES, DOMINANT; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; PENETRANCE; TRANSCRIPTION, GENETIC;

EID: 84866361756     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2012.06.007     Document Type: Article

References (40)

1. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Kay G.N., Le Huezey J.Y., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann L.S., Smith S.C., Priori S.G., Estes N.A., Ezekowitz M.D., Jackman W.M., January C.T., Lowe J.E., Page R.L., Slotwiner D.J., Stevenson W.G., Tracy C.M., Jacobs A.K., Anderson J.L., Albert N., Buller C.E., Creager M.A., Ettinger S.M., Guyton R.A., Halperin J.L., Hochman J.S., Kushner F.G., Ohman E.M., Stevenson W.G., Tarkington L.G., Yancy C.W., American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:e269-e367.
2. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., D'Agostino R.B., Massaro J.M., Beiser A., Wolf P.A., Benjamin E.J. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
3. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98:946-952.
4. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
5. Darbar D., Herron K.J., Ballew J.D., Jahangir A., Gersh B.J., Shen W.K., Hammill S.C., Packer D.L., Olson T.M. Familial atrial fibrillation is a genetically heterogeneous disorder. J. Am. Coll. Cardiol. 2003, 41:2185-2192.
6. Ellinor P.T., Yoerger D.M., Ruskin J.N., MacRae C.A. Familial aggregation in lone atrial fibrillation. Hum. Genet. 2005, 118:179-184.
7. Arnar D.O., Thorvaldsson S., Manolio T.A., Thorgeirsson G., Kristjansson K., Hakonarson H., Stefansson K. Familial aggregation of atrial fibrillation in Iceland. Eur. Heart J. 2006, 27:708-712.
8. Junttila M.J., Raatikainen M.J., Perkiömäki J.S., Hong K., Brugada R., Huikuri H.V. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur. Heart J. 2007, 28:463-468.
9. Christophersen I.E., Ravn L.S., Budtz-Joergensen E., Skytthe A., Haunsoe S., Svendsen J.H., Christensen K. Familial aggregation of atrial fibrillation: a study in Danish twins. Circ. Arrhythm. Electrophysiol. 2009, 2:378-383.
10. Yang Y.Q., Zhang X.L., Wang X.H., Tan H.W., Shi H.F., Fang W.Y., Liu X. Familial aggregation of lone atrial fibrillation in the Chinese population. Intern. Med. 2010, 49:2385-2391.
11. Fox C.S., Parise H., D'Agostino Sr R.B., Lloyd-Jones D.M., Vasan R.S., Wang T.J., Levy D., Wolf P.A., Benjamin E.J. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004, 291:2851-2855.
12. Lubitz S.A., Yin X., Fontes J.D., Magnani J.W., Rienstra M., Pai M., Villalon M.L., Vasan R.S., Pencina M.J., Levy D., Larson M.G., Ellinor P.T., Benjamin E.J. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 2010, 304:2263-2269.
13. Mahida S., Lubitz S.A., Rienstra M., Milan D.J., Ellinor P.T. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc. Res. 2011, 89:692-700.
14. Sinner M.F., Ellinor P.T., Meitinger T., Benjamin E.J., Kääb S. Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc. Res. 2011, 89:701-709.
15. Mommersteeg M.T., Christoffels V.M., Anderson R.H., Moorman A.F. Atrial fibrillation: a developmental point of view. Heart Rhythm. 2009, 6:1818-1824.
16. Salazar M., Consoli F., Villegas V., Caicedo V., Maddaloni V., Daniele P., Caianiello G., Pachón S., Nuñez F., Limongelli G., Pacileo G., Marino B., Bernal J.E., De Luca A., Dallapiccola B. Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects. Eur. J. Med. Genet. 2011, 54:306-309.
17. Gutierrez-Roelens I., De Roy L., Ovaert C., Sluysmans T., Devriendt K., Brunner H.G., Vikkula M. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype?. Eur. J. Hum. Genet. 2006, 14:1313-1316.
18. Boldt L.H., Posch M.G., Perrot A., Polotzki M., Rolf S., Parwani A.S., Huemer M., Wutzler A., Ozcelik C., Haverkamp W. Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation. Int. J. Cardiol. 2010, 145:316-317.
19. Posch M.G., Boldt L.H., Polotzki M., Richter S., Rolf S., Perrot A., Dietz R., Ozcelik C., Haverkamp W. Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur. J. Med. Genet. 2010, 53:201-203.
20. Yang Y.Q., Wang M.Y., Zhang X.L., Tan H.W., Shi H.F., Jiang W.F., Wang X.H., Fang W.Y., Liu X. GATA4 loss-of-function mutations in familial atrial fibrillation. Clin. Chim. Acta 2011, 412:1825-1830.
21. Jiang J.Q., Shen F.F., Fang W.Y., Liu X., Yang Y.Q. Novel GATA4 mutations in lone atrial fibrillation. Int. J. Mol. Med. 2011, 28:1025-1032.
22. Zhang Y., Rath N., Hannenhalli S., Wang Z., Cappola T., Kimura S., Atochina-Vasserman E., Lu M.M., Beers M.F., Morrisey E.E. GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo. Development 2007, 134:189-198.
23. Juang J.M., Chern Y.R., Tsai C.T., Chiang F.T., Lin J.L., Hwang J.J., Hsu K.L., Tseng C.D., Tseng Y.Z., Lai L.P. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int. J. Cardiol. 2007, 116:107-112.
24. Kodo K., Nishizawa T., Furutani M., Arai S., Yamamura E., Joo K., Takahashi T., Matsuoka R., Yamagishi H. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13933-13938.
25. Brewer A., Pizzey J. GATA factors in vertebrate heart development and disease. Expert Rev. Mol. Med. 2006, 8:1-20.
26. Suzuki E., Evans T., Lowry J., Truong L., Bell D.W., Testa J.R., Walsh K. The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics 1996, 38:283-290.
27. Huggon I.C., Davies A., Gove C., Moscoso G., Moniz C., Foss Y., Farzaneh F., Towner P. Molecular cloning of human GATA-6 DNA binding protein: high levels of expression in heart and gut. Biochim. Biophys. Acta 1997, 1353:98-102.
28. Rémond M.C., Iaffaldano G., O'Quinn M.P., Mezentseva N.V., Garcia V., Harris B.S., Gourdie R.G., Eisenberg C.A., Eisenberg L.M. GATA6 reporter gene reveals myocardial phenotypic heterogeneity that is related to variations in gap junction coupling. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1952-H1964.
29. Mead P.E., Brivanlou I.H., Kelley C.M., Zon L.I. BMP-4-responsive regulation of dorsal-ventral patterning by the homeobox protein Mix.1. Nature 1996, 382:357-360.
30. Onichtchouk D., Glinka A., Niehrs C. Requirement for Xvent-1 and Xvent-2 gene function in dorsoventral patterning of Xenopus mesoderm. Development 1998, 125:1447-1456.
31. Kasahara H., Lee B., Schott J.J., Benson D.W., Seidman J.G., Seidman C.E., Izumo S. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest. 2000, 106:299-308.
32. Hodgson-Zingman D.M., Karst M.L., Zingman L.V., Heublein D.M., Darbar D., Herron K.J., Ballew J.D., de Andrade M., Burnett J.C., Olson T.M. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N. Engl. J. Med. 2008, 359:158-165.
33. Gollob M.H., Jones D.L., Krahn A.D., Danis L., Gong X.Q., Shao Q., Liu X., Veinot J.P., Tang A.S., Stewart A.F., Tesson F., Klein G.J., Yee R., Skanes A.C., Guiraudon G.M., Ebihara L., Bai D. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 2006, 354:2677-2688.
34. Yang Y.Q., Zhang X.L., Wang X.H., Tan H.W., Shi H.F., Jiang W.F., Fang W.Y., Liu X. Connexin40 nonsense mutation in familial atrial fibrillation. Int. J. Mol. Med. 2010, 26:605-610.
35. Yang Y.Q., Liu X., Zhang X.L., Wang X.H., Tan H.W., Shi H.F., Jiang W.F., Fang W.Y. Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 2010, 12:1421-1427.
36. Lin X., Huo Z., Liu X., Zhang Y., Li L., Zhao H., Yan B., Liu Y., Yang Y., Chen Y.H. A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. J. Hum. Genet. 2010, 55:662-667.
37. Mommersteeg M.T., Brown N.A., Prall O.W., de Gier-de Vries C., Harvey R.P., Moorman A.F., Christoffels V.M. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ. Res. 2007, 101:902-909.
38. Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Métayer P., Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998, 339:659-666.
39. Nattel S. Basic electrophysiology of the pulmonary veins and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J. Cardiovasc. Electrophysiol. 2003, 14:1372-1375.
40. Mommersteeg M.T., Hoogaars W.M., Prall O.W., de Gier-de Vries C., Wiese C., Clout D.E., Papaioannou V.E., Brown N.A., Harvey R.P., Moorman A.F., Christoffels V.M. Molecular pathway for the localized formation of the sinoatrial node. Circ. Res. 2007, 100:354-362.